Patent · US Active

S100A9 interaction screening method

US8841421B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

Active Biotech AB · SE

Inventors

Per Bjork · Helsingborg, SE
Frederik Ivars · Lund, SE
Tomas Leanderson · Lund, SE

Key dates

Filing date	Apr 24, 2008
Grant date	Sep 23, 2014
Priority date	—
Expiry date	Oct 18, 2030

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/00
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A method of identifying a compound for use in therapy which modulates the interaction of S1OO A9 with a ligand comprising:—determining whether a candidate compound is capable of modulating the interaction of S1OO A9 with RAGE or the interaction of S1OO A9 with a TLR (Toll like receptor), or—determining whether a candidate compound is capable of binding to S100A9 in a manner which disrupts binding of S1OO A9 with RAGE or the binding of S100A9 with a TLR, to thereby identify whether the compound may be used in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.